7
IONS
IONIS PHARMACEUTICALS INC. · Health Care
Consensus score 7/100 · #83 this quarter · tier-weighted across tracked managers
↓DivergingPrice action since filingas of 2026-10-14
vs 50-day avg
-17.7%
21-day momentum
-9.6%
recent volume
0.70×
13F filings lag ~45 days; this is current price/volume action on top — a technical read, not a prediction.
S4· DecliningStage Analysis · Weinstein
vs 30-wk avg
-36.5%
30-wk MA slope
-7.4%
rel. strength
-6.2
52-wk range
1%
Declining — below a falling 30-week trend, lagging the market. Weinstein says avoid. Based on the 30-week (150-day) moving average + slope, Mansfield relative strength vs SPY, and volume. Technical read, not advice.
Holders
2
tracked managers
New this Q
0
opened a position
Avg weight
6.9%
of their portfolios
Combined value
$182M
held, at quarter-end
Who’s holding it Q2 2026, by position size
| Manager | Position size | Value | Change |
|---|---|---|---|
| Tweedy Browne Graham/global value | 13.7% | $181M | HOLD |
| Horizon Kinetics Franchise/inflation | 0.0% | $865K | TRIM |
Position size = share of that manager’s reported long US-equity portfolio. The consensus score weights each holder by quality tier, position size, and whether they were buying or trimming — then discounts very crowded names. It measures agreement among these managers, not expected return.